FDA orders 9 drugmakers to stop selling unapproved narcotics

03/31/2009 | Reuters · USA Today

Glenmark Pharmaceuticals, Boehringer Ingelheim subsidiary Roxane, Covidien's Mallinckrodt unit and six other companies received FDA warnings to stop selling 14 unapproved pain drugs that contain morphine, hydromorphone or oxycodone. Covidien said it will consider seeking FDA approval for its morphine product and comply with the agency's order, and Boehringer said it had submitted a U.S. application for a 4-mg dose of its hydromorphone hydrochloride tablets.

View Full Article in:

Reuters · USA Today

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY